학술논문

A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
Document Type
Journal
Source
MOVEMENT DISORDERS; OCT 27 2023, 11p.
Subject
Language
English
ISSN
15318257